NEW YORK (GenomeWeb News) – Thermo Fisher Scientific late on Thursday priced its offering of $800 million of senior notes at 99.991 percent of the principal amount.

The issuance of the notes is expected to close on or about Nov. 14, the company said. Net proceeds will be used primarily to repay debt, including the $400 million principal amount of its 3.25 percent senior notes due 2014 that mature on Nov. 20.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.